Author:
Tugwell Peter,Tovey David
Reference5 articles.
1. The net -benefit of a treatment should take the correlation between benefits and harms into account;Buyse;JCE,2021
2. Time to improve the reporting of harms in randomized controlled trials;Junqueira;JCE,2021
3. Development of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE);Basch;J Natl Cancer Inst,2014
4. Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials Kathleen M. Andersen, Jonathan T.L. Cheah, Lyn March;Andersen;S J Rheumatol,2019
5. Adverse effects of biologics: a network meta-analysis and Cochrane overview;Singh;Cochrane Database of Systematic Reviews,2011